PETROS PHARMACEUTICALS INC (PTPI) Stock Analyst Earnings Estimates
NASDAQ:PTPI - Nasdaq - US71678J2096 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.81M -18.31% | 5.99M -23.30% | 5.822M -2.80% | 5.543M -4.80% | 5.585M 0.76% | 5.562M -0.41% | 11.277M 102.75% | 22.903M 103.09% | 33.147M 44.73% | 44.567M 34.45% | |
| EBITDA YoY % growth | -11.17M -5.18% | -10.25M 8.24% | -10.334M -0.82% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.05M -4.46% | -15.85M 12.19% | -13.617M 14.09% | -12.044M 11.55% | -12.264M -1.83% | -12.471M -1.68% | -8.428M 32.41% | -6.12K 99.93% | 8.712M 142,452.94% | 17.452M 100.32% | |
| Operating Margin | -231.11% | -264.61% | -233.88% | -217.29% | -219.60% | -224.21% | -74.74% | -0.03% | 26.28% | 39.16% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.17 58.64% | -1.11 48.83% | -1.12 -0.92% | -0.71 36.36% | 0.00 100.00% | 0.73 | 1.47 100.00% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.34 85.30% |
| Revenue Q2Q % growth | 1.309M -77.52% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -3.046M 77.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.53 | -0.30 | -0.23 | -79.18% |
| Q2 2024 Q2Q % growth | -0.37 | -0.79 | 0.42 | 52.89% |
| Q1 2024 Q2Q % growth | -1.69 | -1.47 | -0.22 | -15.06% |
| Q4 2023 Q2Q % growth | -2.29 | -1.13 | -1.16 | -102.26% |
| Q3 2022 Q2Q % growth | -0.67 -294.12% | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.576M -5.87% | 1.367M | 209.37K | 15.32% |
| Q2 2024 Q2Q % growth | 1.421M -28.57% | 1.425M | -3.53K | -0.25% |
| Q1 2024 Q2Q % growth | 1.389M -44.89% | 1.483M | -94.19K | -6.35% |
| Q4 2023 Q2Q % growth | 5.822M 627.80% | 1.584M | 4.238M | 267.58% |
| Q3 2023 Q2Q % growth | 1.675M 214.70% | % | ||
| Q2 2023 Q2Q % growth | 1.99M -52.51% | % | ||
| Q1 2023 Q2Q % growth | 2.52M 2.02% | % | ||
| Q4 2022 Q2Q % growth | 800K 191.95% | % | ||
| Q3 2022 Q2Q % growth | -1.46M -167.91% | % | ||
| Q2 2022 Q2Q % growth | 4.19M 70.33% | % | ||
| Q1 2022 Q2Q % growth | 2.47M -39.46% | % | ||
| Q4 2021 Q2Q % growth | -870K -109.10% | % | ||
| Q2 2021 Q2Q % growth | 2.46M 79.56% | % | ||
| Q1 2021 Q2Q % growth | 4.08M 127.93% | % | ||
| Q4 2020 Q2Q % growth | 9.559M -38.63% | % | ||
| Q2 2020 Q2Q % growth | 1.37M -65.92% | % | ||
| Q1 2020 Q2Q % growth | 1.79M -64.83% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 59.26% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |